查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404857

專題 CDMO 市場規模、佔有率、趨勢分析報告：按產品類型、服務類型、最終用途、地區和細分市場進行預測，2024-2030 年

Topical Drugs CDMO Market Size, Share & Trends Analysis Report By Product Type (Semi-solid Formulations, Liquid Formulations Drugs), By Service Type (Contract Development, Contract Manufacturing), By End-use, By Region, & Segment Forecasts, 2024-2030
出版日期: | 出版商: Grand View Research | 英文 195 Pages | 商品交期: 2-10個工作天內

價格

外用藥物 CDMO 市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球主題CDMO市場規模將達到878.8億美元。

預計2024年至2030年該市場將以11.4%的複合年成長率成長。對治療各種皮膚相關疾病和皮膚病的專門外用藥物的需求日益成長。醫療保健提供者和患者正在尋求客製化解決方案，從而導致對具有外用藥物專業知識的 CDMO 的需求增加。

市場分散，多家公司擁有相似的技術力和加工能力。隨著乳化、奈米技術和經皮吸收貼片創新藥物傳遞技術的發展，CDMO 的能力正在增強，以開發更多對患者友善且有效的外用藥物。此外，個人化醫療的不斷成長趨勢極大地增加了對局部 CDMO 的需求。 CDMO 在根據每位患者的病情和需求個體化局部藥物治療方面發揮著重要作用。

CDMO 與製藥公司之間的合作不斷增加，CDMO 為創新外用藥物的生產和開發做出了貢獻。製藥公司通常選擇外包來專注於研究、分銷和行銷等核心能力，同時將製造服務委託給專業的 CDMO。 FDA核准外用藥物和產品上市的增加極大地促進了專門生產外用藥物的 CDMO 的成長。例如，2022 年 5 月，Dermavant Sciences 的 VTAMA (Tapinarov) Cream 1% 獲得美國食品藥物管理局(FDA)核准，用於局部治療成人斑塊型乾癬。

COVID-19 大流行對市場產生了負面影響。疫情嚴重擾亂了全球供應鏈，影響了製造能力和原料供應。出於安全考慮，一些涉及外用藥物的臨床試驗已暫時推遲或擱置。這阻礙了新的局部治療和製劑的測試和開發。然而，透過採取收購以及與專業藥品供應商合作等策略性舉措，該行業到 2021 年重新奪回了市場佔有率。

專題 CDMO 市場報告亮點

  • 依產品類型分類，半固態製劑產業佔最大的銷售佔有率，2023年將達到66.2%。對乳霜、凝膠和軟膏的需求不斷成長，以及涉及外用藥物的臨床試驗的增加推動了該行業的發展。另一方面，由於針對多種醫療狀況的外用乳膏的核准不斷提高，乳膏子類別佔有很大佔有率。
  • 根據服務類型，契約製造業務在 2023 年佔據最大收入佔有率，達到 63.9%。該領域的高市場佔有率主要是由於製造外包成本效益的推動，對合約製造服務的需求不斷增加。
  • 以最終用途計算，由於更關注與外用藥物開發相關的研發活動，預計生物製藥產業在預測期內的複合年成長率為 11.6%。
  • 預計亞太地區在預測期內的複合年成長率為 12.2%。該地區的顯著成長主要是由於幾個亞洲經濟體的人事費用和營運成本較低，因此外用藥物的生產具有成本效益。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 熱門 CDMO 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 外用藥物 CDMO 市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第4章 外用藥物 CDMO 市場：產品類型估算及趨勢分析

  • 局部藥物 CDMO 市場，依產品類型：細分儀表板
  • 熱門 CDMO 市場（依產品類型）：波動分析
    • 固體製劑
    • 液體製劑藥品
    • 固態製劑
    • 經皮吸收產品

第5章 外用藥物 CDMO 市場：服務類型估計與趨勢分析

  • 局部藥物 CDMO 市場，依服務類型：細分儀表板
  • 外用藥物 CDMO 市場（依服務類型）：波動分析
    • 合約開發
    • 契約製造

第6章 外用藥物 CDMO 市場：最終用途估計與趨勢分析

  • 熱門 CDMO 市場（依最終用途）：細分儀表板
  • 專題 CDMO 市場（依最終用途）：波動分析
    • 製藥公司
    • 生物製藥公司
    • 其他

第7章 外用藥物 CDMO 市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章競爭形勢

  • 市場參與企業分類
    • 創新者
    • 市場領導者
    • 新興玩家
    • 2023 年公司市場佔有率分析
  • 公司簡介
    • Lubrizol Life Science
    • Cambrex Corporation
    • Contract Pharmaceuticals Limited
    • Bora Pharmaceutical CDMO
    • Ascendia Pharmaceuticals
    • Pierre Fabre group
    • Piramal Pharma Solutions
    • DPT Laboratories, LTD
    • MedPharm Ltd
    • PCI Pharma Services
Product Code: GVR-4-68040-150-0

Topical Drugs CDMO Market Growth & Trends:

The global topical drugs CDMO market size is expected to reach USD 87.88 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.4% from 2024 to 2030. There is an increasing need for specialized topical drugs to address various skin-related and dermatological conditions. Healthcare providers and patients seek customized solutions, leading to a rise in demand for CDMOs with specialized expertise in topical drugs.

The market is fragmented, with several players having similar technological and processing capabilities. The development of innovative drug delivery technologies, such as microemulsions, nanotechnology, and transdermal patches, has extended the abilities of CDMOs to create more patient-friendly and effective topical drug products. Furthermore, a growing trend towards personalized medicine has significantly boosted demand for topical drug CDMOs, as they play a fundamental role in personalizing topical treatments to individual patient conditions and needs.

Collaborations between CDMOs and pharmaceutical companies have risen, with CDMOs contributing to the manufacturing and development of innovative and new topical drugs. Pharmaceutical firms significantly opt for outsourcing with an aim to focus on core competencies such as research, distribution, and marketing while entrusting manufacturing services to dedicated CDMOs. The increasing number of FDA approvals and product launches in topical medications significantly contributes to CDMOs specializing in topical drug manufacturing growth. For instance, in May 2022, Dermavant Sciences received the U.S. Food and Drug Administration (FDA) approval for its VTAMA (tapinarof) cream, 1%, for the topical management of plaque psoriasis in adults.

The COVID-19 pandemic negatively impacted the market. The pandemic has significantly disrupted the global supply chains, affecting the accessibility of manufacturing capabilities and raw materials. Several clinical studies, including those for topical medicine, were temporarily delayed or put on hold owing to safety concerns. This disturbed the testing and development of new topical drug treatments and formulations. However, by adopting strategic initiatives such as acquisition and partnerships with specialized drug providers, the industry regained its market shares by 2021.

Topical Drugs CDMO Market Report Highlights:

  • Based on product type, the semi-solid formulations segment held the largest revenue share of 66.2% in 2023.The segment is driven by the growing demand for creams, gels, and ointments and the rise in clinical trials involving topical drugs. The cream sub-category, on the other hand, held the lion's share owing to increasing approval of topical creams for several medical conditions
  • Based on the service type, the contract manufacturing segment held the largest revenue share of 63.9% in 2023. The high shares of the segment are majorly due to the growing demand for outsourced manufacturing services, driven by the cost-effectiveness of outsourced manufacturing
  • In terms of end-use, the biopharmaceutical companies segment is anticipated to witness the fastest CAGR of 11.6% over the forecast period owing to the rise in focus on R&D activities pertaining to the development of topical medication
  • Asia Pacific is anticipated to register the fastest CAGR of 12.2% over the forecast period. The region's substantial growth is primarily attributed to the cost-effective manufacturing of topical products due to lower labor and operational costs in several Asian economies

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
    • 1.1.2. Product Type
    • 1.1.3. Service Type
    • 1.1.4. End-use
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective-1
    • 1.4.2. Objective-2
    • 1.4.3. Objective-3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Topical Drugs CDMO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High demand for non-invasive treatment options to boost sales of topical drugs
      • 3.2.1.2. Growing pipeline of topical drugs
      • 3.2.1.3. Growing research and development investments
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Compliance with strict regulatory requirements
      • 3.2.2.2. Limited efficacy in certain conditions limits adoption of topical products
  • 3.3. Topical Drugs CDMO Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat Of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Topical Drugs CDMO Market: Product Type Estimates & Trend Analysis

  • 4.1. Topical Drugs CDMO Market, By Product Type: Segment Dashboard
  • 4.2. Topical Drugs CDMO Market, By Product Type: Movement Analysis
  • 4.3. Topical Drugs CDMO Market Estimates & Forecasts, By Product Type, 2018 - 2030
    • 4.3.1. Semi-solid Formulations
      • 4.3.1.1. Semi-solid Formulations Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
      • 4.3.1.2. Creams
      • 4.3.1.2.1. Creams Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
      • 4.3.1.3. Ointments
      • 4.3.1.3.1. Ointments Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
      • 4.3.1.4. Gel
      • 4.3.1.4.1. Gel Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
      • 4.3.1.5. Others
      • 4.3.1.5.1. Others Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
    • 4.3.2. Liquid Formulations Drugs
      • 4.3.2.1. Liquid Formulations Drugs Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
    • 4.3.3. Solid Formulations
      • 4.3.3.1. Solid Formulations Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
    • 4.3.4. Transdermal Products
      • 4.3.4.1. Transdermal Products Topical Drugs CDMO Market, 2018 to 2030 (USD Million)

Chapter 5. Topical Drugs CDMO Market: Service Type Estimates & Trend Analysis

  • 5.1. Topical Drugs CDMO Market, By Service Type: Segment Dashboard
  • 5.2. Topical Drugs CDMO Market, By Service Type: Movement Analysis
  • 5.3. Topical Drugs CDMO Market Estimates & Forecasts, By Service Type, 2018 - 2030
    • 5.3.1. Contract Development
      • 5.3.1.1. Contract Development Topical Drugs CDMO Market, 2018 to 2030 (USD Million)
    • 5.3.2. Contract Manufacturing
      • 5.3.2.1. Contract Manufacturing Topical Drugs CDMO Market, 2018 to 2030 (USD Million)

Chapter 6. Topical Drugs CDMO Market: End-use Estimates & Trend Analysis

  • 6.1. Topical Drugs CDMO Market, By End-use: Segment Dashboard
  • 6.2. Topical Drugs CDMO Market, By End-use: Movement Analysis
  • 6.3. Topical Drugs CDMO Market Estimates & Forecasts, By End-use, 2018 - 2030
    • 6.3.1. Pharmaceutical Companies
      • 6.3.1.1. Pharmaceutical Companies Topical Drugs CDMO Market 2018 to 2030 (USD Million)
    • 6.3.2. Biopharmaceutical Companies
      • 6.3.2.1. Biopharmaceutical Companies Topical Drugs CDMO Market 2018 to 2030 (USD Million)
    • 6.3.3. Others
      • 6.3.3.1. Others Topical Drugs CDMO Market 2018 to 2030 (USD Million)

Chapter 7. Topical Drugs CDMO Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Competitive Scenario
      • 7.5.1.3. Regulatory Framework
      • 7.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 7.5.2. Germany
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Competitive Scenario
      • 7.6.1.3. Regulatory Framework
      • 7.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 7.6.2. India
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 7.6.4. South Korea
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Competitive Scenario
      • 7.7.1.3. Regulatory Framework
      • 7.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 7.7.2. Mexico
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Competitive Scenario
      • 7.8.1.3. Regulatory Framework
      • 7.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
    • 8.1.1. Innovators
    • 8.1.2. Market Leaders
    • 8.1.3. Emerging Players
    • 8.1.4. Company Market Share Analysis, 2023
  • 8.2. Company Profiles
    • 8.2.1. Lubrizol Life Science
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Service Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Cambrex Corporation
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Service Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Contract Pharmaceuticals Limited
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Service Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Bora Pharmaceutical CDMO
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Service Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Ascendia Pharmaceuticals
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Service Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Pierre Fabre group
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Service Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Piramal Pharma Solutions
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Service Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. DPT Laboratories, LTD
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Service Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. MedPharm Ltd
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Service Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. PCI Pharma Services
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Service Benchmarking
      • 8.2.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 5 North America Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 6 North America Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 7 North America Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 11 U.S. Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 12 Canada Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 13 Canada Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 15 Canada Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 16 Europe Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
  • Table 17 Europe Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 18 Europe Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 19 Europe Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 20 Europe Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 21 UK Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 22 UK Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 23 UK Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 24 UK Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 25 Germany Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 28 Germany Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 France Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 30 France Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 31 France Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 32 France Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 33 Italy Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 35 Italy Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 36 Italy Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 37 Spain Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 38 Spain Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 39 Spain Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 40 Spain Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 41 Denmark Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 42 Denmark Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 43 Denmark Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 44 Denmark Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 45 Sweden Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 46 Sweden Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 48 Sweden Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 49 Norway Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 50 Norway Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 51 Norway Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 52 Norway Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 China Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 59 China Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 60 China Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 61 China Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 62 Japan Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 63 Japan Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 65 Japan Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 66 India Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 67 India Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 68 India Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 69 India Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 Australia Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 71 Australia Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 72 Australia Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 73 Australia Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 74 South Korea Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 75 South Korea Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 77 South Korea Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 78 Thailand Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 79 Thailand Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 80 Thailand Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 81 Thailand Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 82 Latin America Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
  • Table 83 Latin America Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 84 Latin America Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 85 Latin America Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 86 Latin America Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Brazil Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 88 Brazil Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 89 Brazil Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 90 Brazil Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 91 Mexico Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 92 Mexico Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 93 Mexico Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 94 Mexico Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 95 Argentina Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 96 Argentina Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 97 Argentina Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 98 Argentina Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa Topical Drugs CDMO market, by region, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 102 Middle East & Africa Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 103 Middle East and Africa Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 104 South Africa Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 105 South Africa Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 106 South Africa Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 107 South Africa Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 112 UAE Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 113 UAE Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 114 UAE Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 115 UAE Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)
  • Table 116 Kuwait Topical Drugs CDMO market, by Service Type, 2018 - 2030 (USD Million)
  • Table 117 Kuwait Topical Drugs CDMO market, by Product Type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait Topical Drugs CDMO market, by Semi-solid Formulations, 2018 - 2030 (USD Million)
  • Table 119 Kuwait Topical Drugs CDMO market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Primary research pattern
  • Fig. 8 Primary interviews in North America
  • Fig. 9 Primary interviews in Europe
  • Fig. 10 Primary interviews in the Asia Pacific
  • Fig. 11 Primary interviews in Latin America
  • Fig. 12 Primary interviews in MEA
  • Fig. 13 Market Snapshot
  • Fig. 14 Segment Snapshot
  • Fig. 15 Segment Snapshot
  • Fig. 16 Competitive Landscape Snapshot
  • Fig. 17 Topical Drugs CDMO market segmentation
  • Fig. 18 Parent market outlook (2023)
  • Fig. 19 Related/ancillary market outlook (2023)
  • Fig. 20 Market driver relevance analysis (Current & future impact)
  • Fig. 21 Market restraint relevance analysis (Current & future impact)
  • Fig. 22 Porter's five forces analysis
  • Fig. 23 SWOT analysis, by a factor (political & legal, economic and technological)
  • Fig. 24 Topical Drugs CDMO Market Product Type outlook: Segment dashboard
  • Fig. 25 Topical Drugs CDMO: Product Type movement analysis
  • Fig. 26 Semi-solid Formulations market, 2018 - 2030 (USD Million)
  • Fig. 27 Creams market, 2018 - 2030 (USD Million)
  • Fig. 28 Ointments market, 2018 - 2030 (USD Million)
  • Fig. 29 Gel market, 2018 - 2030 (USD Million)
  • Fig. 30 Others market, 2018 - 2030 (USD Million)
  • Fig. 31 Liquid Formulations Drugs market, 2018 - 2030 (USD Million)
  • Fig. 32 Solid Formulations market, 2018 - 2030 (USD Million)
  • Fig. 33 Transdermal Products market, 2018 - 2030 (USD Million)
  • Fig. 34 Topical Drugs CDMO Market Service Type outlook: Segment dashboard
  • Fig. 35 Topical Drugs CDMO: Service Type type movement analysis
  • Fig. 36 Contract Development market, 2018 - 2030 (USD Million)
  • Fig. 37 Contract Manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 38 Topical Drugs CDMO market End-use outlook: Segment dashboard
  • Fig. 39 Topical Drugs CDMO market: End-use movement analysis
  • Fig. 40 Pharmaceutical Companies market, 2018 - 2030 (USD Million)
  • Fig. 41 Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
  • Fig. 42 Others market, 2018 - 2030 (USD Million)
  • Fig. 43 Regional marketplace: Segment dashboard
  • Fig. 44 Regional outlook, 2023 & 2030
  • Fig. 45 North America market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada market, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market, 2018 - 2030 (USD Million)
  • Fig. 49 Germany market, 2018 - 2030 (USD Million)
  • Fig. 50 UK market, 2018 - 2030 (USD Million)
  • Fig. 51 France market, 2018 - 2030 (USD Million)
  • Fig. 52 Italy market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain market, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark market, 2018 - 2030(USD Million)
  • Fig. 55 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 56 Norway market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 58 China market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan market, 2018 - 2030 (USD Million)
  • Fig. 60 India market, 2018 - 2030 (USD Million)
  • Fig. 61 Australia market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East & Africa market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 71 UAE market, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait market, 2018 - 2030 (USD Million)